Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Phase 3 symbols : Avdl save search
Avadel Pharmaceuticals Announces Publication of Positive Secondary Endpoint Data from Pivotal Phase 3 REST-ON Trial
Published: 2022-04-06 (Crawled : 19:00) - biospace.com/
AVDL | $17.4 0.12% 920K
|
Health Technology
|
| O: -0.9%
H: 2.87%
C: 1.06%
trial positive phase 3
Avadel Recognizes World Narcolepsy Day and Announces New Data Presentations from Pivotal Phase 3 REST-ON Trial of FT218 at Upcoming Conference
Published: 2021-09-20 (Crawled : 14:00) - biospace.com/
AVDL | $17.4 0.12% 920K
|
Health Technology
|
| O: -1.76%
H: 2.43%
C: 1.02%
presentation narcolepsy phase 3 ft218 trial conference
Avadel Pharmaceuticals Announces Publication of Data from Pivotal Phase 3 REST-ON Trial of FT218 in Adults with Narcolepsy in SLEEP
Published: 2021-08-16 (Crawled : 12:15) - globenewswire.com
AVDL | $17.4 0.12% 920K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -6.54%
narcolepsy phase 3 ft218 trial
Avadel Presents New Clinical Data from Pivotal Phase 3 REST-ON Trial Supporting Clinical Benefit of FT218 in Patients with Narcolepsy at SLEEP 2021
Published: 2021-06-09 (Crawled : 13:00) - globenewswire.com
AVDL | $17.4 0.12% 920K
|
Health Technology
|
| O: 1.13%
H: 1.12%
C: -0.37%
phase 3 ft218 trial narcolepsy
Avadel to Present New Efficacy and Safety Data from Pivotal Phase 3 REST-ON Trial of FT218 at SLEEP 2021
Published: 2021-06-03 (Crawled : 14:00) - globenewswire.com
AVDL | $17.4 0.12% 920K
|
Health Technology
|
| O: 1.38%
H: 0.5%
C: -2.1%
phase 3 ft218 trial
Avadel Presents New Data from its Pivotal REST-ON Phase 3 Trial of FT218, once-nightly sodium oxybate, at the 2021 American Academy of Neurology Annual Meeting
Published: 2021-04-17 (Crawled : 12:20) - globenewswire.com
AVDL | $17.4 0.12% 920K
|
Health Technology
| Email alert
Add to watchlist
phase 3 ft218 trial sodium oxybate
Avadel to Present New Data from its Pivotal REST-ON Phase 3 Study of FT218 at the American Academy of Neurology Annual Meeting 2021
Published: 2021-04-08 (Crawled : 15:00) - biospace.com/
AVDL | $17.4 0.12% 920K
|
Health Technology
|
| O: 2.32%
H: 3.63%
C: -0.34%
phase 3 ft218
Gainers vs Losers
| 71% | 29% |
Top 10 Gainers
AGBA | News | $1.27 217.5% 120M
|
Finance
EGOX | $0.0503 39.72% 320M
|
RWOD | $10.52 31.56% 5.9M
|
n/a
ZCMD | $1.905 31.38% 30M
|
Commercial Services
MRDB 4 | $0.536 27.65% 2M
|
n/a
BSFC | $0.0822 27.64% 75M
|
Manufacturing
TPET | $0.4121 25.68% 45M
|
n/a
NVFY | $2.65 25.59% 33M
|
Consumer Durables
INDO | $5.1 25.0% 15M
|
Energy Minerals
CHRO | $1.53 24.9% 100K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.